ABH Optics ApS

ABH Optics has developed a novel type of eyeglass lens using cutting-edge nanotechnology, originating from DTU Health Tech's projects. With an exclusive IP license from DTU and based on extensive previous research funding from DTU, the Innovation Fund Denmark, and the EU, the company is poised to disrupt the traditional lens manufacturing process, which has remained largely unchanged for centuries. The company's proprietary technology allows for easy customization of lenses, addressing both optical power and structural defects. The result is a product line of ultra-thin, lightweight, and environmentally friendly lenses that reduce plastic usage. ABH Optics targets the 13% of eyeglass wearers with prescriptions exceeding +/- 4 dioptres, who will greatly benefit from the new lens technology. • ABH Optics, a pioneer in the eyewear industry, secures €1 million pre-seed funding from HTGF for Groundbreaking Meta Optics Lenses. • Developed at DTU, ABH Optics' individualized meta-optic lenses offer unparalleled precision and efficiency. • The company’s lenses, even for strong prescriptions up to +/-20 diopters, will be only 1 mm thick.